Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
Operating Expenses | 0 | 4,732 | 4,473 | 0 | 0 |
Operating Income | N/A | -4,732 | -4,473 | N/A | N/A |
Other Income | 0 | -1,340 | 163 | -4,494 | 0 |
Pre-tax Income | 0 | -6,072 | -4,310 | -4,494 | 0 |
Income Tax | N/A | -21 | 6 | 7 | N/A |
Net Income Continuous | N/A | -6,051 | -4,316 | N/A | N/A |
Net Income | $N/A | $-6,051 | $-4,316 | $N/A | $N/A |
EPS Basic Total Ops | N/A | -15.62 | -13.51 | -14.11 | N/A |
EPS Basic Continuous Ops | N/A | -15.66 | -13.38 | N/A | N/A |
EPS Diluted Total Ops | N/A | -15.62 | -13.51 | -14.11 | N/A |
EPS Diluted Continuous Ops | N/A | -15.66 | -13.38 | N/A | N/A |
EBITDA(a) | $N/A | $-4,559 | $-4,091 | $N/A | $N/A |